KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Hematology / 2019 / Cilt: 36 - Sayı: 1

Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality

Süreyya BOZKURT
Mufide OKAY
İbrahim HAZNEDAROĞLU
Sayfa
62–63
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

BOZKURT, S., OKAY, M., HAZNEDAROĞLU, İ. (2019). Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality. Turkish Journal of Hematology, Cilt: 36 - Sayı: 1, 62–63. https://ajindex.com/articles/412350

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Sawyer JR. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma. Cancer Genet 2011;204:3-12
  2. Huret JL. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2017. Available at
  3. Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, 2017. Available at http://cgap.nci. nih.gov/Chromosomes/Mitelman
  4. Huret JL. t(3;16)(q21;q22). Atlas Genet Cytogenet Oncol Haematol 2009;13:747
  5. Neri G, Daniel A, Hammond N. Chromosome 16q, eosinophilia, and leukemia. Cancer Genet Cytogenet 1985;14:371-372
  6. Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Davies F, Chen-Kiang S, Durie BG, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loiseau H; International Myeloma Working Group. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 2009;23:2210-2221.